Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | inositol-4-monophosphate | 39 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 46 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 49 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 54 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 55 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 56 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 56 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 62 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 66 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 75 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 78 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 79 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 94 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 96 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 100 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 109 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 113 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 124 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 126 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 148 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 149 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 156 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 159 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 161 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 163 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 167 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 167 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 169 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 170 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 186 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 189 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 195 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 202 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 208 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 214 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 218 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 226 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 227 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 233 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 239 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 245 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 262 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 275 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | inositol-4-monophosphate | 278 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 293 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 317 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 364 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 393 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 401 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 402 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 403 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 477 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 631 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 665 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 755 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 759 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 846 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | inositol-4-monophosphate | 1218 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |